AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 223 filers reported holding AMICUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,165,854 | -6.6% | 178,113 | -3.5% | 0.01% | 0.0% |
| Q2 2023 | $2,318,312 | +7.5% | 184,579 | -5.0% | 0.01% | +16.7% |
| Q1 2023 | $2,155,608 | -16.5% | 194,374 | -8.1% | 0.01% | -25.0% |
| Q4 2022 | $2,581,585 | +10.2% | 211,432 | -5.8% | 0.01% | +14.3% |
| Q3 2022 | $2,343,000 | -8.4% | 224,438 | -5.8% | 0.01% | 0.0% |
| Q2 2022 | $2,559,000 | -21.9% | 238,258 | -31.2% | 0.01% | 0.0% |
| Q1 2022 | $3,278,000 | -18.0% | 346,100 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $3,997,000 | +20.9% | 346,100 | 0.0% | 0.01% | +14.3% |
| Q3 2021 | $3,305,000 | -0.9% | 346,100 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $3,336,000 | -2.4% | 346,100 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $3,419,000 | -58.5% | 346,100 | -2.9% | 0.01% | -63.2% |
| Q4 2020 | $8,229,000 | +42.9% | 356,400 | -12.6% | 0.02% | +35.7% |
| Q3 2020 | $5,760,000 | -6.4% | 407,900 | 0.0% | 0.01% | -17.6% |
| Q2 2020 | $6,151,000 | +68.6% | 407,900 | +3.3% | 0.02% | +41.7% |
| Q1 2020 | $3,648,000 | +8.2% | 394,800 | +14.0% | 0.01% | +50.0% |
| Q4 2019 | $3,373,000 | +21.5% | 346,300 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $2,777,000 | -18.1% | 346,300 | +27.5% | 0.01% | -11.1% |
| Q2 2019 | $3,390,000 | -6.1% | 271,600 | +2.3% | 0.01% | -10.0% |
| Q1 2019 | $3,612,000 | +92.9% | 265,600 | +35.9% | 0.01% | +66.7% |
| Q4 2018 | $1,872,000 | -19.7% | 195,400 | +1.3% | 0.01% | 0.0% |
| Q3 2018 | $2,331,000 | -22.6% | 192,800 | 0.0% | 0.01% | -33.3% |
| Q2 2018 | $3,012,000 | +22.0% | 192,800 | +17.5% | 0.01% | +28.6% |
| Q1 2018 | $2,468,000 | +4.5% | 164,100 | 0.0% | 0.01% | +16.7% |
| Q4 2017 | $2,361,000 | +49.1% | 164,100 | +56.3% | 0.01% | +20.0% |
| Q3 2017 | $1,583,000 | +49.8% | 105,000 | 0.0% | 0.01% | +66.7% |
| Q2 2017 | $1,057,000 | – | 105,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |